orm-13070
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00735774)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
Loading structure…
SMILES
COCc1cccnc1N1CCN(C[C@H]2COc3ccccc3O2)CC1- Mol. weight
- 355.44 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4302506 ↗
Also known as
- orm-13070
- orm-13070
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00735774 | Phase 1 | Aug 1, 2008 | Orion Corporation, University of Turku |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Orion Corporation | For profit | 1 | 1 | 1 | 2008 |
| University of Turku | Academic/Hospital | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1